Evoke Pharma Inc.

Join this Action
Practice Area:
Stock Symbol: EVOK
Case Status: Investigations

The Ademi Firm is investigating Evoke (NASDAQ: EVOK) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction.

In the transaction, Evoke shareholders will receive $11.00 per share in cash through a tender offer. Evoke insiders will receive substantial benefits as part of change of control arrangements.

The transaction agreement unreasonably limits competing transactions for Evoke by imposing a significant penalty if Evoke accepts a competing bid. We are investigating the conduct of the Evoke board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

Join this Action